anti-inflammatory
– Preclinical and early clinical studies of MYMD-1®, an oral, small-molecule, selective TNF-α inhibitor accepted for presentation – BALTIMORE, November 17, 2022–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious and debilitating autoimmune and inflammatory diseases, has been invited to present late-breaking data […]
The results support the successful identification of specific cannabis varieties with anti-inflammatory and pain relief properties, for which Canonic recently filed a patent application REHOVOT, Israel, Jan. 18, 2022 /PRNewswire/ — Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today positive results in pre-clinical […]
Big Pharma Dives Into CBD: Who Could Be Next?
As many of you know, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) agreed in early February to acquire GW Pharmaceuticals plc (NASDAQ: GWPH) for a total price tag, including cash and shares, of $7.2 billion. GW Pharma is a pioneer in cannabinoid-based medicine, and its cannabidiol (CBD) formulation Epidiolex® is notably the first plant-derived cannabinoid medicine ever […]
CBD Innovator, HempFusion, Makes Successful Debut on TSX
HempFusion Wellness Inc. (TSX: CBD-U) shares soared over 65% following their successful debut on the Toronto Stock Exchange (TSX) on Wednesday, January 6, 2021. Cannabidiol, or CBD, has become one of the most popular health and wellness products in the world over the past couple of years. According to Research and Markets, the global […]
HempFusion Gears Up for IPO on the TSX
HempFusion Wellness Inc., a leading health and wellness CBD company, recently closed the order book for its proposed initial public offering (IPO), marking another step closer to becoming a publicly-traded company on the Toronto Stock Exchange (TSX) over the coming months. Completion of this proposed initial public offering has the potential to accelerate the company’s […]
CBD Makes Its Way into Mainstream Retail
The U.S. market for CBD products is projected to reach $23.7 billion by 2023, according to Brightfield Group, representing a seven-fold increase in the market’s size. While it’s one of the fastest-growing subsets of the multi-trillion-dollar wellness industry, CBD products remain absent from most mass-market retailers. CVS became the first large-scale retailer to offer CBD […]
Trial will take place at major U.S. centers and examine the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease (CVD) Oakville, Ontario–(Newsfile Corp. – September 25, 2020) – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (“Cardiol” or the “Company“), a clinical-stage biotechnology company focused […]
Cannabidiol Phase 1 Clinical Trial Launches, Targeting Inflammatory Heart Condition
Cannabidiol, or CBD, is thought to be beneficial for a wide variety of ailments, ranging from poor sleep to pain to PTSD and beyond. To this point, however, there haven’t been many clinical trials conducted to thoroughly prove or disprove the benefits of CBD. So far, it has been approved by the U.S. Food and […]
Science-driven Brand Delivers 5 Perfected Cannabis Highs
What happens when the investment environment surrounding cannabis companies evaporates amid concerns about overvaluations and lack of returns? And then, a worldwide pandemic reverses years of economic growth almost overnight, plunging economies into near-instant depression? One thing that happens is some quality companies become distressed, offering investors the opportunity to purchase a stake at a […]
Coping With Stress During the COVID-19 Outbreak with CBD & Adaptogens
The COVID-19 outbreak has become a major source of stress over the past several weeks. In addition to the fear and anxiety of disease, quarantines and “stay at home” orders have contributed to stress levels, leading to poor sleep, unhealthy eating, and other side-effects. It’s important for everyone to take inventory of their health and […]
Canibrands Capitalizes on CBD with Deep Product Line & Celebrity Support
Cannabidiol, better known as CBD, has become one of the most popular wellness products in the United States over the past couple of years. BDS Analytics and Arcview Market Research expect CBD sales to grow at a 49% compound annual growth rate to surpass $20 billion by 2024—making up about half of the total cannabinoid […]
Europe: The Cannabis Industry’s Next Emerging Market
The global cannabis industry is projected to reach $66.3 billion by 2025, according to Grand View Research, representing a 23.9 percent compound annual growth rate. While North America has become a market leader, European markets are quickly catching up with their own liberalized laws. The market for health and wellness products, such as cannabidiol (CBD) […]
cbdMD Sales Growing, Key Influencers Continue to Bring the Product Mainstream
CBD, or cannabidiol, has moved into the mainstream, a normalization process that has been supported by several regulatory and legislative events. The framework may be on the government side, but consumer uptake is being accelerated by key influencers promoting brands while educating the public on these events, as well as the potential benefits of […]
The Yield Growth: Building A Cannabis Lifestyle Product Empire
Ayurveda is an ancient medicine system dating back thousands of years in India. In Sanskrit, the word means “The Science of Life.” In the simplest sense, it is a holistic approach to healing – including medicating with cannabis – in a harmonious manner with the Earth, including locally sourcing natural ingredients. For The Yield Growth […]
The Yield Growth Corp.: Headed by a Team of Powerful Women Leaders
As an emerging and relatively new line of business, cannabis has already proven itself to be a powerhouse of a market. The global cannabis industry’s revenue ballooned to US $12.2 billion in 2018, with predictions that it will reach $16.9 billion in 2019, according to BDS Analytics. The burgeoning industry is setting trends in […]
Cannabis M&A Spree Continues with Supreme’s Merger with Blissco
The cannabis industry is quickly moving through a well-known cycle for emerging markets. Like Google in the tech industry, early market entrants that have become successful in a given subset of the fragmented market are starting to look to mergers and acquisitions to expand their geographic and product footprint. The result is often a mature […]
XPhyto Therapeutics Ready to Be Cannabis’ Newest Public Entity
Only days after announcing that its wholly owned subsidiary was awarded a German cannabis and cultivation and extraction licence, XPhyto Therapeutics is ready to enter the public domain. With a final prospectus filed with the British Columbia Securities Commission, XPhyto is ready to go public on the CSE under the ticker “XPHY”. The company will […]
CannabisFN Profile: Recognizable Cannabis Advocate, Steve DeAngelo & Harborside Inc.
There are many celebrities that have been involved in the cannabis industry, but few have been as actively involved in the community as Steve DeAngelo. As a pioneering cannabis entrepreneur, activist, author and on-screen personality, DeAngelo co-founded several iconic cannabis businesses and organizations and continues to play an instrumental role in reforming cannabis laws through […]
Synthetic Cannabinoids: The New Age of Medical Marijuana
Believe it or not, the world’s first blockbuster drug is still one of the most commonly used today. Acetylsalicylic acid, better known as Aspirin®, is a synthetic derivative of the natural substance salicylic acid, an extract from the bark of the white willow tree. Any company would like to invent a drug that enjoys 100+ […]
The Yield Growth Corp.: Leading The Way in The Luxury Cosmeceutical CBD Market
The last six weeks have seen major strides taken by The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (Frankfurt:YG3) to maintain their position as an exciting, forward-thinking and innovative cannabis company. An organisation dedicated to disrupting the wellness industry with revolutionary cannabis and hemp-based products, Yield Growth continues to make advances; it has released new products, continued […]
Nabis™ Expands National Footprint with California Acquisition
There are many multi-state operators seeking a slice of the $14.5 billion U.S. cannabis industry, but few have the ambition and expertise of Nabis Holdings Inc. (CSE: NAB) (OTC: INNPF) (FRA: 7IP). Staying true to its name, meaning ‘repeat performance’ or ‘encore’, the co-founders behind MPX Bioceuticals Corp. (CSE: MPX), which was purchased by iAnthus […]
Betting Big on the New Age of Synthetic Cannabinoids
In the U.S. and globally, there is an explosion in demand for cannabinoids, naturally occurring components of the cannabis plant, for medical research purposes. The overarching problem, however, is that the natural extraction technologies that dominate the field today are chock full of issues, including high costs and potential for contamination. While the bias still […]
Nabis™ Founders Look to Repeat Success & Build a Leading Cannabis MSO
Nabis Holdings Inc. (CSE: NAB) was founded by two of the four founders of MPX Bioceutical Corp. (CSE: MPX), which was one of the first companies to successfully become a multi-state operator, or MSO, in the United States. In October 2018, MPX was acquired by iAnthus Capital Holdings Inc. (OTCQX: ITHUF) for C$835 million in […]
As a new industry, the next few months will be pivotal for the development of the cannabis market. With laws changing every month in jurisdictions around the globe, the room for growth is huge as the industry continues to mature. A recent study by Statista showed that in 2018, the global sales of hemp amounted […]
MediPharm Labs Executing on International Cannabis Extracts Strategy
Canadian companies have a bit of a head start on those from other countries where the legal cannabis framework is not as comprehensive or advanced. In many ways, countries around the globe look to Canada as a model. In fact, Australia has basically adopted Canadian medical regulations and is a few years behind Canada in […]
Yield Growth’s New Subsidiary, Wright & Well, Positioned to Disrupt the Wellness Market
The Yield Growth Corp. (CSE: BOSS) has proven itself a serious contender in the legal cannabis market, and will be a particularly exciting candidate to follow as the industry continues to evolve from just flower to other cannabis based products. Yield Growth’s flagship brand, Urban Juve, produces exceptional wellness and beauty items, rooted in ancient […]
TransCanna Acquires Massive Vertically Integrated Cannabis Facility in California
California’s cannabis industry is projected to generate more than $6.5 billion in annual revenue by 2020, according to New Frontier Data and Arcview Market Research, which represents a 23.1% compound annual growth rate. Many companies are racing to build their production footprint, introduce new brands, expand distribution, and open new dispensaries, but few have reached […]
YIELD GROWTH Announces Development of 10 New Hemp Root Oil Infused Products Exclusively for Men
VANCOUVER, British Columbia, April 18, 2019 (GLOBE NEWSWIRE) — The Yield Growth Corp. (CSE:BOSS) (OTCQB:BOSQF) (Frankfurt:YG3) is pleased to announce it is developing a unique selection of Urban Juve products exclusively for men. Featuring amber and tobacco—two ingredients with ancient origins—the new products under development include beard oil, hair gel, aftershave moisturizer, shaving cream, sex balm and […]
Why Branding Matters in the Cannabis Industry
The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. While the industry is known for strain names, like OG Kush and Girl Scout Cookies, there aren’t established marquee brands like those found in tobacco or pharmaceutical industries—which has […]
Harvest One Ensures Cannabis Supply with Greenbelt Acquisition
Vertical integration has become kind of a buzzword in the cannabis industry over the last few years. Many companies claim it as a goal, with the intent of controlling the whole supply chain for their products from seed-to-sale. Getting to that level of control can prove difficult, however, as the resources, equipment, and expertise required […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
In addition to his role as Founder and CEO at MAZAKALI, Sumit is a consultant to The Arcview Group and the Managing Partner of Emerald Ventures. A frequent speaker at investment seminars, Sumit acts as a mentor to Arcview and Canopy companies and serves on the Canopy Investment committee as well as the NCIA Finance […]
Tom Zuber is Zuber Lawler & Del Duca’s Managing Partner. He has a degree with highest honors in biomedical engineering and has advised some of the most iconic companies in the world on their patent and trademark portfolios. He is at the cutting edge of cannabis patent and trademark law. He holds degrees from Harvard University and Columbia Law […]
TruTrace Technologies has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry.
Fiore Cannabis (CSE:FIOR) (OTCQX:FIORF) is a publicly-traded company that has been investing in the development of medical and recreational cannabis products since 2014.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
